Maldini, C., Druce, K., Basu, N., LaValley, M. P. & Mahr, A. Exploring the variability in Behçet’s disease prevalence: a meta-analytical approach. Rheumatology 57, 185–195 (2018).

Article  PubMed  Google Scholar 

Davatchi, F. et al. Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev. Clin. Immunol. 13, 57–65 (2007).

Article  Google Scholar 

Kappen, J. H. et al. Behçet’s disease, hospital-based prevalence and manifestations in the Rotterdam area. Neth. J. Med. 73, 471–477 (2015).

CAS  PubMed  Google Scholar 

Emmi, G., Bettio, I. A., Hatemi, G. & Prisco, D. Behçet’s syndrome. Lancet 403, 1093–1108 (2024).

Article  CAS  PubMed  Google Scholar 

Mattioli, I., Bettio, I. A., Saruhan-Direskeneli, G., Direskeneli, H. & Emmi, G. Pathogenesis of Behcet’s syndrome: genetic, environmental and immunological factors. Front. Med. 8, 713052 (2021).

Article  Google Scholar 

Bettiol, A. et al. Epigenetic regulation of thrombo-inflammation in Behçet and antiphospholipid syndrome. J. Transl. Autoimmun. 11, 100293 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Emmi, G. et al. A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome. Ann. Rheum. Dis. 81, 386–397 (2022).

Article  CAS  PubMed  Google Scholar 

Emmi, G. et al. Butyrate-rich diets improve redox status and fibrin lysis in Behçet’s syndrome. Circ. Res. 128, 278–280 (2021).

Article  CAS  PubMed  Google Scholar 

Bettiol, A., Emmi, G., Low, L., Sofi, F. & Wallace, G. R. Microbiome in Behcet’s syndrome. Clin. Immunol. 250, 109304 (2023).

Article  CAS  PubMed  Google Scholar 

Becatti, M. et al. Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behçet disease. Circulation 133, 302–311 (2016).

Article  CAS  PubMed  Google Scholar 

Bettiol, A. et al. Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behcet’s syndrome. Clin. Exp. Immunol. 206, 410–421 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Joncour, A. et al. Critical role of neutrophil extracellular traps (NETs) in patients with Behcet’s disease. Ann. Rheum. Dis. 78, 1274–1282 (2019).

Article  PubMed  Google Scholar 

Hatemi, G., Uçar, D., Uygunoğlu, U., Yazici, H. & Yazici, Y. Behçet Syndrome. Rheum. Dis. Clin. North. Am. 49, 585–602 (2023).

Article  PubMed  Google Scholar 

Mumcu, G. et al. Oral health is impaired in Behçet’s disease and is associated with disease severity. Rheumatology 43, 1028–1033 (2004).

Article  CAS  PubMed  Google Scholar 

International Team for the Revision of the International Criteria for Behçet’s Disease The international criteria for Behçet’s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J. Eur. Acad. Dermatol. Venereol. 28, 338–347 (2014).

Article  Google Scholar 

Hatemi, G. et al. Core set of domains for outcome measures in Behçet’s syndrome. Arthritis Care Res. 74, 691–699 (2022).

Article  Google Scholar 

Grigor, C. et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364, 263–269 (2004).

Article  PubMed  Google Scholar 

Hao, Y., Oon, S. & Nikpour, M. Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: a systematic review and meta-analysis. Semin. Arthritis. Rheum. 67, 152465 (2024).

Article  CAS  PubMed  Google Scholar 

Smolen, J. S. et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann. Rheum. Dis. 75, 3–15 (2016).

Article  PubMed  Google Scholar 

Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann. Rheum. Dis. 82, 3–18 (2023).

Article  CAS  PubMed  Google Scholar 

Verstappen, S. M. et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann. Rheum. Dis. 66, 1443–1449 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Eijk, I. et al. Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial. Rheumatology 51, 686–694 (2012).

Article  PubMed  Google Scholar 

Urata, Y., Nakamura, Y. & Furukawa, K. Comparison of initial versus delayed introduction of a treat-to-target strategy in patients with recent-onset rheumatoid arthritis: results of the T-4 3-year study. Ann. Rheum. Dis. 73, 470–472 (2014).

Article  PubMed  Google Scholar 

Harrold, R. L. et al. Cluster-Randomized trial of a behavioral intervention to incorporate a treat-to-target approach to care of US patients with rheumatoid arthritis. Arthritis Care Res. 70, 379–387 (2018).

Article  Google Scholar 

Nair, C. S. et al. Economic evaluation of a tight-control treatment strategy using an imaging device (hand scan) for monitoring joint inflammation in early rheumatoid arthritis. Clin. Exp. Rheumatol. 33, 831–838 (2015).

CAS  PubMed  Google Scholar 

Vermeer, M. et al. Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet. Disord. 14, 350–358 (2013).

Article  PubMed  PubMed Central  Google Scholar 

van Vollenhoven, R. F. et al. Treat-to-target in systemic lupus erythematosus: Recommendations from an international task force. Ann. Rheum. Dis. 73, 958–967 (2014).

Article  PubMed  Google Scholar 

Fanouriakis, A. et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann. Rheum. Dis. 83, 15–29 (2024).

Article  CAS  PubMed  Google Scholar 

Piga, M. et al. Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force. Autoimmun. Rev. 24, 103773 (2025).

Article  CAS  PubMed  Google Scholar 

Parra Sánchez, A. R., Voskuyl, A. E. & van Vollenhoven, R. F. Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat. Rev. Rheumatol. 18, 146–157 (2022).

Article  PubMed  Google Scholar 

Gvozdenović, E. et al. When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS). RMD Open. 2, e000221 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Pirri, S. et al. Adherence to treatment in Behçet’s syndrome: a multi-faceted issue. Clin. Exp. Rheumatol. 132, 88–93 (2021).

Article  Google Scholar 

Hatemi, G. A treat-to-target approach is needed for Behçet’s syndrome. Curr. Opin. Rheumatol. 34, 39–45 (2022).

Article  PubMed  Google Scholar 

Fragoulis, G. E. et al. Treat to target in Behcet’s disease: should we follow the paradigm of other systemic rheumatic diseases? Clin. Immunol. 246, 109186 (2023).

Article  CAS  PubMed  Google Scholar 

Hatemi, G. et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann. Rheum. Dis. 77, 808–818 (2018).